TIHRF yields 2.04% · JNJ yields 2.13%● Live data
📍 TIHRF pulled ahead of the other in Year 1
Combined, TIHRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TIHRF + JNJ for your $10,000?
Tharisa plc, an investment holding company, engages in the mining, processing, beneficiation, marketing, sale, and logistics of platinum group metals (PGM) and chrome concentrates in South Africa, China, Singapore, Hong Kong, Australia, Japan, and internationally. It operates through four segments: PGM, Chrome, Agency and Trading, and Manufacturing. The company's PGM basket includes platinum, palladium, rhodium, gold, ruthenium, iridium, nickel, and copper. It holds 100% interest in the Tharisa mine, an open pit PGM and chrome mine located on the south-western limb of the Bushveld Complex, South Africa. The company also offers chemical and foundry grade chrome concentrates; and metallurgical grade chrome concentrate for stainless steel and ferrochrome producers, as well as commodity traders. In addition, it is involved the manufacturing of mining equipment. The company was incorporated in 2008 and is based in Paphos, Cyprus.
Full TIHRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.